CNRP Mining Inc. (CSE:CND) (OTCQB:CRPGF), is pleased to announce that X-SPRAYS has signed an exclusive distribution agreement with a national distributor of consumer packaged goods in Europe. Under the terms of the agreement the Distributor will supply X-SPRAYS products to the following countries: Germany, Austria and Switzerland.
The Distributor has a 10-year history and multiple existing retail channels, including pharmacies, drug stores and a robust online presence. X-SPRAYS products will be supplied leveraging the Distributor’s extensive network and this partnership provides X-SPRAYS with unique access to the European market. The Company will begin shipping products to the Distributor in early Q1-2018, pending necessary approvals. With a population exceeding 82 million people and federal insurance coverage for cannabis, Germany represents the world’s largest legal cannabis market.
“We are excited to have partnered with an established and recognized leader in the European consumer packaged goods marketplace. This agreement allows us to utilize an existing network with wide reach to immediately create a presence in the world’s largest federally legislated medicinal cannabis market,” said Mr. John Knapp, CEO of X-SPRAYS.
X-SPRAYS is comprised of dedicated scientists and product engineers who are passionate about health and creating the ultimate delivery system for optimal nutrition. The company has focused its efforts on creating a product line of oral sprays to deliver medicines, nutrients and vitamins. To date, X-SPRAYS has developed a novel line of 8 health care and life enhancement nutraceutical products focused on areas such as pain, energy, libido and sleep.
The Company’s product line is ready for commercialization with 8 novel sprays that include both hemp cannabidiol (CBD) and nutraceutical ingredients. X-SPRAYS intends to expand its product line to include cannabis tetrahydrocannabinol (THC) and additional CBD sprays. For more information, please visit the company’s website at: www.x-sprays.com.
ON BEHALF OF THE BOARD
For further information, please contact: